Callyaerin B

General Information


DRACP ID  DRACP05036

Peptide Name   Callyaerin B

Sequence  XIXIILPPLPII

Sequence Length  12

UniProt ID  Not available

PubChem CID  Not available

Origin 

Type 

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic 

Disulfide/Other Bond  Native peptide

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C57H96N10O9

Absent amino acids  ACDEFGHKMNQRSTVWY

Common amino acids  I

Mass  148185

Pl  6.11

Basic residues  0

Acidic residues  0

Hydrophobic residues  7

Net charge  0

Boman Index  3444

Hydrophobicity  210.83

Aliphatic Index  227.5

Half Life 
  /

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 26213786

Title  Not available

Doi Not available

Year  Not available

Literature 2

Pubmed ID 20599387

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  9852

DRACP is developed by Dr.Zheng's team.